Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population

doi:10.1371/journal.pone.0229484

CNU IR > College of Sustainable Environment and Recreation > Dept. of Occupational Safety > Periodical Articles > Item 310902800/34083

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34083

Title:	Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population
Authors:	Yeh, Jun-Jun Lin, Cheng-Li Kao, Chia-Hung
Contributors:	Chia Yi Christian Hosp, Ditmanson Med Fdn Chia Nan Univ Pharm & Sci China Med Univ China Med Univ Hosp, Management Off Hlth Data China Med Univ, Coll Med China Med Univ Hosp, Ctr Augmented Intelligence Healthcare China Med Univ, Coll Med, Grad Inst Biomed Sci China Med Univ Hosp, Dept Nucl Med China Med Univ Hosp, PET Ctr Asia Univ, Dept Bioinformat & Med Engni
Date:	2020
Issue Date:	2022-11-18 11:23:12 (UTC+8)
Publisher:	Public Library Science
Abstract:	Purpose To evaluate the association among chronic obstructive pulmonary disease (COPD) with asthma, steroid use, and pneumonia in the general population. Methods Using Taiwan's National Health Insurance Research Database to identify patients with incident pneumonia, we established a COPD with asthma cohort of 12,538 patients and a COPD cohort of 25,069 patients. In both cohorts, the risk of incident pneumonia was assessed using multivariable Cox proportional hazards models. Results The adjusted hazard ratio (aHR) with 95% confidence interval (CI) for incident pneumonia was 2.38 (2.14, 2.66) in the COPD with asthma cohort, regardless of age, sex, comorbidities, and drug use. COPD cohort without inhaled corticosteroids (ICSs) use served as a reference. The aHR (95% CI) for COPD cohort with ICSs use was 1.34 (0.98, 1.83); that for COPD with asthma cohort without ICSs use was 2.46 (2.20, 2.76); and that for COPD with asthma cohort with ICSs use was 2.32 (1.99, 2.72). COPD cohort without oral steroids (OSs) use served as a reference; the aHR (95% CI) for COPD with asthma cohort without OSs use and with OSs use was 3.25 (2.72, 3.89) and 2.38 (2.07, 2.74), respectively. Conclusions The COPD with asthma cohort had a higher risk of incident pneumonia, regardless of age, sex, comorbidities, and ICSs or OSs use. COPD cohort with ICSs use did not have a notable risk of incident pneumonia. The COPD with asthma cohort had a higher risk of incident pneumonia, even without ICSs/OSs use.
Relation:	Plos One, v.15, n.2, pp.17
Appears in Collections:	[Dept. of Occupational Safety] Periodical Articles

Files in This Item:

File	Description	Size	Format
10.1371_journal.pone.0229484.pdf		914Kb	Adobe PDF	117	View/Open
index.html		0Kb	HTML	899	View/Open

Loading...